| For: | Beales ILP, Hensley A, Loke Y. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition. World J Gastrointest Pharmacol Ther 2013; 4(3): 69-79 [PMID: 23919219 DOI: 10.4292/wjgpt.v4.i3.69] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v4/i3/69.htm |
| Number | Citing Articles |
| 1 |
Mark R. Wendling, Brant K. Oelschlager. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; doi: 10.1016/B978-0-323-40232-3.00033-9
|
| 2 |
Oliver J. Old, L. Max Almond, Hugh Barr, Janusz Jankowski. Esophageal Cancer. 2015; doi: 10.1007/978-3-319-20068-2_5
|
| 3 |
Laura Galli, Vincenzo Spagnuolo, Andrea Poli, Stefania Salpietro, Nicola Gianotti, Francesca Cossarini, Alessia Carbone, Silvia Nozza, Simona Bossolasco, Alba Bigoloni, Adriano Lazzarin, Antonella Castagna. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy. AIDS 2014; 28(16) doi: 10.1097/QAD.0000000000000443
|
| 4 |
Sarang Jang, Hyo Geun Choi, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, So Young Kim. Relation of Statin Use with Esophageal Cancer. Pharmaceuticals 2023; 16(6) doi: 10.3390/ph16060900
|
| 5 |
Parisa Karimi, Farhad Islami, Sharmila Anandasabapathy, Neal D. Freedman, Farin Kamangar. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(5) doi: 10.1158/1055-9965.EPI-13-1057
|
| 6 |
Qi-Jun Wu, Chao Tu, Yuan-Yuan Li, Jingjing Zhu, Ke-Qing Qian, Wen-Jing Li, Lang Wu. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 2015; 6(40) doi: 10.18632/oncotarget.5557
|
| 7 |
Pavana Thomas, Annapurna Pranatharthi, Cecil Ross, Sweta Srivastava. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1327-4
|
| 8 |
Jonathan V. S. Wong, Ali Fatehi Hassanabad. Targeting the Mevalonate Pathway for Treating Esophageal Cancer. Journal of Gastrointestinal Cancer 2021; 52(2) doi: 10.1007/s12029-021-00644-8
|
| 9 |
Huai Yi Chen, Chia Rou Por, Yong Kai Hong, Eason Qi Zheng Kong, Vetriselvan Subramaniyan. Molecular mechanisms underlying oesophageal cancer development triggered by chronic alcohol consumption. Clinical and Translational Discovery 2024; 4(6) doi: 10.1002/ctd2.70021
|
| 10 |
Nanda Provoost, Rebecca C. Fitzgerald, Judith Honing. Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives. Best Practice & Research Clinical Gastroenterology 2025; 75 doi: 10.1016/j.bpg.2025.101989
|
| 11 |
Simona Pisanti, Paola Picardi, Elena Ciaglia, Alba D’Alessandro, Maurizio Bifulco. Novel prospects of statins as therapeutic agents in cancer. Pharmacological Research 2014; 88 doi: 10.1016/j.phrs.2014.06.013
|
| 12 |
Annapurna Pranatharthi, Cecil Ross, Sweta Srivastava, Zhi Sheng. Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/5785786
|
| 13 |
Stefanos Bonovas. Statins: Do They Have a Potential Role in Cancer Prevention and Modifying Cancer-Related Outcomes?. Drugs 2014; 74(16) doi: 10.1007/s40265-014-0309-2
|
| 14 |
Aleksandra M. Urbanska, Selvarangan Ponnazhagan, Masoud Mozafari. Pathology, Chemoprevention, and Preclinical Models for Target Validation in Barrett Esophagus. Cancer Research 2018; 78(14) doi: 10.1158/0008-5472.CAN-18-0206
|
| 15 |
Katie E O’Sullivan, James J Phelan, Ciara O’Hanlon, Joanne Lysaght, Jacintha N O’Sullivan, John V Reynolds. The role of inflammation in cancer of the esophagus. Expert Review of Gastroenterology & Hepatology 2014; 8(7) doi: 10.1586/17474124.2014.913478
|
| 16 |
O J Old, L M Almond, H Barr. Barrett's oesophagus: how should we manage it?. Frontline Gastroenterology 2015; 6(2) doi: 10.1136/flgastro-2014-100552
|
| 17 |
Wanqing Chen, Rongshou Zheng, Siwei Zhang, Hongmei Zeng, Yaguang Fan, Youlin Qiao, Qinghua Zhou. Esophageal cancer incidence and mortality in China, 2010. Thoracic Cancer 2014; 5(4) doi: 10.1111/1759-7714.12100
|
| 18 |
Elizabeth Long, Ian L.P. Beales. The role of obesity in oesophageal cancer development. Therapeutic Advances in Gastroenterology 2014; 7(6) doi: 10.1177/1756283X14538689
|
| 19 |
Sunil Samnani, Janusz A. Jankowski, Paul Moayyedi. Chemoprevention in Barrett’s Esophagus: An Updated Review. Gastrointestinal Endoscopy Clinics of North America 2026; 36(1) doi: 10.1016/j.giec.2025.05.004
|
| 20 |
Yanfang Qiu, Jie You, Kunlun Wang, Yuan Cao, Youchun Hu, Han Zhang, Rong Fu, Yafei Sun, Huanan Chen, Ling Yuan, Quanjun Lyu. Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial. Nutrition 2020; 69 doi: 10.1016/j.nut.2019.110558
|
| 21 |
Theresa Nguyen, Zhigang Duan, Aanand D. Naik, Jennifer R. Kramer, Hashem B. El-Serag. Statin Use Reduces Risk of Esophageal Adenocarcinoma in US Veterans With Barrett’s Esophagus: A Nested Case-Control Study. Gastroenterology 2015; 149(6) doi: 10.1053/j.gastro.2015.07.009
|
| 22 |
Jan Martínek, Jun‐ichi Akiyama, Zuzana Vacková, Manuele Furnari, Edoardo Savarino, Teus J. Weijs, Elen Valitova, Sylvia van der Horst, Jelle P. Ruurda, Lucas Goense, George Triadafilopoulos. Current treatment options for esophageal diseases. Annals of the New York Academy of Sciences 2016; 1381(1) doi: 10.1111/nyas.13146
|
| 23 |
L. Max Almond, Oliver Old, Hugh Barr. Strategies for the prevention of oesophageal adenocarcinoma. International Journal of Surgery 2014; 12(9) doi: 10.1016/j.ijsu.2014.07.273
|
| 24 |
Tom Thomas, Yoon Loke, Ian L. P. Beales. Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma. Journal of Gastrointestinal Cancer 2018; 49(4) doi: 10.1007/s12029-017-9983-0
|
| 25 |
Chris R. Cardwell, Andrew D. Spence, Carmel M. Hughes, Liam J. Murray. Statin use after esophageal cancer diagnosis and survival: A population based cohort study. Cancer Epidemiology 2017; 48 doi: 10.1016/j.canep.2017.04.015
|
| 26 |
Michael J. Gonyeau. The Spectrum of Statin Therapy in Cancer Patients: Is There a Need for Further Investigation?. Current Atherosclerosis Reports 2014; 16(1) doi: 10.1007/s11883-013-0383-z
|
| 27 |
Su Liu, Harpreet Uppal, Marco Demaria, Pierre-Yves Desprez, Judith Campisi, Pankaj Kapahi. Simvastatin suppresses breast cancer cell proliferation induced by senescent cells. Scientific Reports 2015; 5(1) doi: 10.1038/srep17895
|
| 28 |
Ruby Kasana, Christy Thomas, Gaurav Das, Munlima Hazarika, Krishna Undela. Statin use and risk of cancer. Annals of Oncology Research and Therapy 2023; 3(1) doi: 10.4103/aort.aort_34_22
|
| 29 |
Ali Fatehi Hassanabad, Jonathan V. S. Wong. Statins as Potential Therapeutics for Esophageal Cancer. Journal of Gastrointestinal Cancer 2021; 52(3) doi: 10.1007/s12029-021-00648-4
|
| 30 |
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, Giovanni Targher. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers. Metabolism 2024; 160 doi: 10.1016/j.metabol.2024.156014
|
| 31 |
Gregoire F. Le Bras, Muhammad H. Farooq, Gary W. Falk, Claudia D. Andl. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacological Research 2016; 113 doi: 10.1016/j.phrs.2016.08.021
|
| 32 |
ABDULLAH K. ALTWAIRGI. Statins are potential anticancerous agents (Review). Oncology Reports 2015; 33(3) doi: 10.3892/or.2015.3741
|
| 33 |
Ian L. P. Beales, Leanne Dearman, Inna Vardi, Yoon Loke. Reduced Risk of Barrett’s Esophagus in Statin Users: Case–Control Study and Meta-Analysis. Digestive Diseases and Sciences 2016; 61(1) doi: 10.1007/s10620-015-3869-4
|
| 34 |
S Zhang, X-Q Zhang, X-W Ding, R-K Yang, S-L Huang, F Kastelein, M Bruno, X-J Yu, D Zhou, X-P Zou. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a meta-analysis. British Journal of Cancer 2014; 110(9) doi: 10.1038/bjc.2014.127
|
| 35 |
Yong Zhang, Weijia Kong, Jiandong Jiang. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms. Science China Life Sciences 2017; 60(6) doi: 10.1007/s11427-017-9047-4
|
| 36 |
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Lina Leiss, Bente Sandvei Skeie, Per Øyvind Enger. Drug repurposing in cancer. Pharmacological Research 2017; 124 doi: 10.1016/j.phrs.2017.07.013
|
| 37 |
Victoria Wocalewski, Giola Santoni, Helgi Birgisson, My Von Euler-Chelpin, Joonas H Kauppila, Eivind Ness-Jensen, Shaohua Xie, Jesper Lagergren. Menopausal hormone therapy and risk of esophageal and gastric cancer in a multinational study. JNCI: Journal of the National Cancer Institute 2026; doi: 10.1093/jnci/djag072
|
| 38 |
Gwang Hun Jeong, Keum Hwa Lee, Jong Yeob Kim, Michael Eisenhut, Andreas Kronbichler, Hans J. van der Vliet, Sung Hwi Hong, Jae Il Shin, Gabriele Gamerith. Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2019; 8(6) doi: 10.3390/jcm8060819
|
| 39 |
Motasem Alkhayyat, Prabhat Kumar, Krishna O. Sanaka, Prashanthi N. Thota. Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211033730
|